Grasim Industries Ltd
Grasim Industries Limited is the flagship company of the Aditya Birla group, it ranks amongst India's largest private sector companies. On standalone basis, GIL’s core businesses comprise of viscose Staple fibre (VSF), caustic soda, speciality chemicals, rayon-grade wood pulp (RGWP) with plants at multiple locations. It also has certain other businesses such as fertiliser, textile, etc. [1]
- Market Cap ₹ 1,74,745 Cr.
- Current Price ₹ 2,599
- High / Low ₹ 2,878 / 1,944
- Stock P/E 150
- Book Value ₹ 835
- Dividend Yield 0.38 %
- ROCE 3.75 %
- ROE 2.70 %
- Face Value ₹ 2.00
Pros
- Company has been maintaining a healthy dividend payout of 40.9%
Cons
- Stock is trading at 3.11 times its book value
- Company has a low return on equity of 4.46% over last 3 years.
- Earnings include an other income of Rs.1,002 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Textiles Industry: Textiles - Manmade
Part of BSE Dollex 200 BSE 500 BSE India Manufacturing Index BSE SENSEX 50 BSE Dividend Stability Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,255 | 5,567 | 6,300 | 8,969 | 10,346 | 15,786 | 20,550 | 16,082 | 12,386 | 20,857 | 26,840 | 25,847 | 27,685 | |
4,167 | 4,706 | 5,635 | 7,473 | 8,189 | 12,696 | 16,479 | 13,946 | 10,822 | 17,641 | 23,649 | 23,531 | 25,986 | |
Operating Profit | 1,088 | 861 | 665 | 1,496 | 2,157 | 3,090 | 4,071 | 2,135 | 1,564 | 3,216 | 3,190 | 2,316 | 1,699 |
OPM % | 21% | 15% | 11% | 17% | 21% | 20% | 20% | 13% | 13% | 15% | 12% | 9% | 6% |
639 | 385 | 322 | 326 | 472 | 179 | -1,800 | 270 | 527 | 1,182 | 920 | 541 | 1,002 | |
Interest | 39 | 42 | 39 | 147 | 58 | 128 | 199 | 238 | 236 | 247 | 368 | 440 | 529 |
Depreciation | 159 | 220 | 263 | 445 | 446 | 628 | 760 | 814 | 828 | 914 | 1,097 | 1,215 | 1,390 |
Profit before tax | 1,529 | 985 | 685 | 1,230 | 2,125 | 2,513 | 1,312 | 1,354 | 1,027 | 3,237 | 2,645 | 1,202 | 782 |
Tax % | 20% | 9% | 23% | 21% | 27% | 30% | 61% | 5% | 12% | 6% | 20% | 21% | |
1,226 | 896 | 530 | 971 | 1,560 | 1,769 | 515 | 1,288 | 905 | 3,051 | 2,124 | 945 | 464 | |
EPS in Rs | 25.84 | 18.88 | 11.17 | 20.12 | 32.33 | 26.03 | 7.58 | 18.95 | 13.31 | 44.85 | 31.21 | 14.36 | 6.93 |
Dividend Payout % | 17% | 22% | 31% | 22% | 16% | 23% | 89% | 20% | 65% | 22% | 31% | 70% |
Compounded Sales Growth | |
---|---|
10 Years: | 17% |
5 Years: | 5% |
3 Years: | 28% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | 17% |
TTM: | -23% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 26% |
3 Years: | 14% |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 4% |
3 Years: | 4% |
Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 92 | 92 | 92 | 93 | 93 | 131 | 132 | 132 | 132 | 132 | 132 | 133 | 134 |
Reserves | 10,030 | 10,736 | 11,091 | 13,778 | 16,138 | 44,658 | 41,828 | 37,560 | 42,816 | 48,484 | 46,823 | 51,982 | 54,869 |
1,284 | 1,302 | 1,115 | 1,839 | 701 | 2,969 | 3,311 | 5,158 | 4,223 | 4,384 | 5,352 | 9,729 | 10,622 | |
1,660 | 1,748 | 2,067 | 2,085 | 2,919 | 5,959 | 6,524 | 6,729 | 7,529 | 9,636 | 9,871 | 12,294 | 13,639 | |
Total Liabilities | 13,066 | 13,878 | 14,365 | 17,796 | 19,851 | 53,718 | 51,794 | 49,579 | 54,700 | 62,636 | 62,177 | 74,138 | 79,264 |
2,072 | 3,548 | 5,188 | 6,963 | 6,887 | 10,817 | 11,232 | 12,234 | 10,966 | 14,858 | 16,220 | 17,105 | 20,418 | |
CWIP | 2,425 | 1,807 | 450 | 318 | 375 | 745 | 1,567 | 2,793 | 4,033 | 1,743 | 2,926 | 7,131 | 5,100 |
Investments | 6,224 | 5,604 | 5,350 | 7,100 | 8,996 | 35,547 | 31,128 | 27,542 | 33,640 | 38,691 | 33,897 | 39,212 | 41,538 |
2,345 | 2,919 | 3,377 | 3,416 | 3,592 | 6,609 | 7,867 | 7,009 | 6,060 | 7,345 | 9,135 | 10,689 | 12,209 | |
Total Assets | 13,066 | 13,878 | 14,365 | 17,796 | 19,851 | 53,718 | 51,794 | 49,579 | 54,700 | 62,636 | 62,177 | 74,138 | 79,264 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
854 | 62 | 448 | 1,341 | 2,259 | 2,353 | 2,556 | 3,315 | 2,402 | 2,656 | 2,319 | 1,778 | |
-1,157 | 221 | 27 | -697 | -844 | -1,910 | -2,263 | -4,277 | -875 | -1,896 | -2,190 | -5,586 | |
309 | -274 | -448 | -663 | -1,404 | -451 | -299 | 993 | -1,509 | -777 | -165 | 3,840 | |
Net Cash Flow | 5 | 10 | 27 | -19 | 12 | -9 | -7 | 31 | 18 | -17 | -36 | 32 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 35 | 40 | 40 | 40 | 42 | 60 | 62 | 66 | 39 | 30 | 22 | 28 |
Inventory Days | 113 | 149 | 146 | 132 | 131 | 129 | 110 | 131 | 143 | 153 | 127 | 141 |
Days Payable | 49 | 55 | 49 | 49 | 84 | 113 | 89 | 132 | 174 | 180 | 133 | 148 |
Cash Conversion Cycle | 98 | 134 | 137 | 124 | 89 | 77 | 83 | 65 | 8 | 2 | 16 | 21 |
Working Capital Days | 35 | 66 | 72 | 56 | 29 | 39 | 43 | 25 | -33 | -20 | -14 | -7 |
ROCE % | 11% | 8% | 5% | 10% | 13% | 9% | 8% | 4% | 2% | 6% | 6% | 4% |
Documents
Announcements
-
Grant Of Stock Options And Performance Stock Unit Scheme 2022
1d - Grant of 22,987 stock options to employees.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
20 Nov - Intimation of loss of share certificates.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
19 Nov - Transcript of Q2 FY '25 Earnings Conference Call.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Apr 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018Transcript PPT
-
Nov 2017Transcript PPT
-
Aug 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Aug 2016TranscriptNotesPPT
-
Oct 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Strong Parentage[1]
Grasim is a part of Aditya Birla Group which is one of the largest business groups of India. Group's key companies include Grasim, Hindalco, Ultratech, Aditya Birla Capital, Century, Fashion and Retail, Vodafone etc.